Clinical Trials on Hepatobiliary Malignancies in Australia
Total 70 results
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
Hutchison Medipharma LimitedIqvia Pty LtdUnknownHematologic MalignanciesAustralia
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Clover Biopharmaceuticals AUS Pty LtdCompletedPeritoneal MalignanciesAustralia
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid MalignanciesAustralia
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced MalignanciesAustralia, China
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
Melbourne HealthActive, not recruitingHaematological MalignancyAustralia
-
Bayside HealthThe Alfred; The Leukaemia Foundation of VictoriaUnknownRCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMTHematological MalignanciesAustralia
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, Germany, United Kingdom
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Antengene Discovery LimitedRecruitingAdvanced Solid Tumors | Hematological MalignanciesAustralia
-
BeiGeneCompletedB-cell Lymphoid MalignanciesAustralia, Korea, Republic of, United States
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
Atridia Pty Ltd.CompletedSolid Tumors and Hematologic MalignancyAustralia
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
Antengene Therapeutics LimitedBristol-Myers SquibbRecruitingSolid Tumor | Hematological MalignancyAustralia
-
Elisabethinen HospitalPfizerTerminated
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid Malignancies or LymphomasAustralia
-
Ascentage Pharma Group Inc.RecruitingHematologic MalignanciesUnited States, Australia
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
Medical University of ViennaCompleted
-
Melbourne HealthPeter MacCallum Cancer Centre, Australia; Western Sydney Local Health District and other collaboratorsEnrolling by invitationCytomegalovirus Infections | Immune Suppression | Haematological Malignancy | Organ or Tissue Transplant; ComplicationsAustralia
-
AbbVieRecruitingHematologic MalignanciesUnited States, Australia
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
The Hospital for Sick ChildrenBristol-Myers SquibbTerminatedRefractory or Recurrent Hypermutated Malignancies | Biallelic Mismatch Repair Deficiency (bMMRD) Positive PatientsUnited States, France, Canada, Australia, Israel
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
AstraZenecaTerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesHaematological MalignanciesFrance, Italy, United States, Korea, Republic of, Germany, Australia
-
AccentureCompletedHematologic MalignanciesKorea, Republic of, Australia, Canada
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Forma Therapeutics, Inc.CompletedCohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) | Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) | Cohort 3a and 3b: Chondrosarcoma | Cohort 4a and 4b: Intrahepatic... and other conditionsUnited States, Korea, Republic of, Australia, United Kingdom, Spain, France
-
Robert Krause, MDCompletedInvasive Fungal Infection | Hematological Malignancy | Receipt of Solid Organ TransplantAustria
-
Medical University of ViennaRoche Pharma AG; Allcyte GmbHRecruitingRefractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell LymphomaAustria
-
GlaxoSmithKlineCompletedNeoplasmsSpain, United States, Korea, Republic of, United Kingdom, Australia
-
Centre Hospitalier Universitaire VaudoisUnknownHematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold InfectionsSwitzerland, Austria, Germany
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Incyte CorporationRecruitingB-Cell MalignanciesUnited States, Spain, Belgium, Japan, Italy, France, United Kingdom, Israel, Turkey, Norway, Korea, Republic of, Czechia, Sweden, Austria, Poland, Hungary, Denmark
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, Belgium, Australia, Spain
-
Heidelberg UniversityCompleted
-
AmgenCompletedCarcinoma | Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumors | Oncology | Tumors | Metastases | Gynecological MalignanciesBelgium, United States, Australia
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel